Genetic testing for medications, sometimes called pharmacogenomic testing, looks at a few genes that can influence how your body processes certain medicines. The goal is simple. Use your biology to help choose a medication and dose that is more likely to work well and more likely to be tolerated. It is one more tool to personalize care, not a magic answer. Genome.gov+1

What pharmacogenomic testing can do

  • Help guide choice and dosing. Your genes can affect how quickly you metabolize a medication, which can change both benefit and side effects. Using that information can help identify people who are more likely to respond, avoid adverse effects, and find a safer starting dose. U.S. Food and Drug Administration

  • Provide insight that lasts. Your DNA does not change, so your results remain useful over time and can be shared with your other clinicians. M Health Fairview

  • Support shared decisions. Results are combined with your diagnosis, history, and preferences so you and your clinician can decide together. Genome.gov

What it cannot do

  • It does not diagnose conditions. The test does not tell you whether you have depression, anxiety, ADHD, or any other condition. MedlinePlus

  • It does not reveal family history or disease risk. Pharmacogenetic panels focus on how your body may handle medicines, not on your risk for unrelated diseases. MedlinePlus

  • It does not guarantee an outcome. Many factors shape response to treatment, including other medicines, health conditions, sleep, nutrition, stress, and support. Your genes are one piece of a larger picture. Mayo Clinic

Common genes and medicines in mental health

Two of the most discussed genes in psychiatry are CYP2D6 and CYP2C19. They help your body process many antidepressants and other medicines. Clinical guidelines outline how results can inform starting doses or medication selection for selective serotonin reuptake inhibitors and related medicines. cpicpgx.org

A few practical examples:

  • Antidepressants. For some antidepressants, results that indicate very slow or very fast metabolism can guide dose adjustments or a different choice within the class. cpicpgx.org

  • Atomoxetine for ADHD. The medication label recommends dosing changes for people who are CYP2D6 poor metabolizers or who take strong CYP2D6 inhibitors. FDA Access Data+1

  • Codeine. Not a psychiatric medicine, but a clear illustration. People who are CYP2D6 ultra rapid metabolizers can convert codeine to morphine very quickly, which can be dangerous. This is why codeine labeling and safety communications highlight genetics. FDA Access Data+1

  • Carbamazepine. Used in neurology and sometimes in mood care. People of certain Asian ancestries should be screened for the HLA B*1502 variant before starting because of the risk of severe skin reactions. ClinPGx+1

If a medicine you are considering is in the Food and Drug Administration table of drugs with pharmacogenomic information, your clinician may use those details alongside your results. U.S. Food and Drug Administration

Who might benefit from testing

  • You have tried several medicines with limited benefit or difficult side effects. CDC

  • You are starting a medicine that has clear gene based dosing guidance. cpicpgx.org+1

  • You take many medications that may interact and want a more tailored plan. Genome.gov

  • You have a family history of unusual reactions to specific medicines. Genome.gov

  • You are of an ancestry where a specific safety gene is relevant for a planned medicine, such as HLA B*1502 and carbamazepine. ClinPGx

Genetics is helpful, but not required, for good care. Many people do well without testing. Your clinician will help you decide whether it adds value for you right now. Mayo Clinic Health System

What to expect from the process

  1. Conversation and consent. We talk through what the test can and cannot show and answer your questions. MedlinePlus

  2. Sample collection. Most tests use a simple cheek swab. The sample is sent to a lab for analysis. AACAP

  3. Results. Reports list your predicted metabolizer status for certain genes. We translate that into plain language and connect it to the medicines you take or may take. Genome.gov

  4. Plan. We decide together whether to adjust a dose, change a medicine, or stay the course and monitor. For some medicines, guidelines suggest specific dose ranges based on your result. cpicpgx.org

  5. Share the information. Because results remain relevant, we encourage you to share them with your other providers and keep a copy for future care. M Health Fairview

How results are used in real decisions

  • Starting an antidepressant. If your results predict very slow metabolism for a specific agent, we may choose a lower starting dose or a different antidepressant within the same class, based on guideline tables. cpicpgx.org

  • Tuning ADHD treatment. If atomoxetine is a good fit but your results indicate slow metabolism, we may start lower and increase more slowly, as reflected in the medication label. FDA Access Data

  • Avoiding risk. If a planned medicine carries a known genetic safety risk for your ancestry, we will consider a different option or arrange specific screening first. ClinPGx

Privacy, coverage, and cost

Pharmacogenomic tests report how you process medicines. They do not report disease risk or family history. Coverage varies by insurer and by reason for testing. Our team can help you understand your plan and the steps involved. MedlinePlus+1

Clear expectations and common questions

Will this test tell me the perfect medicine for me
No single test can do that. Results narrow the field and guide safer choices, and we still rely on your goals and your experience over time. Genome.gov

If my results say I am a fast or slow metabolizer, does that mean a medicine will not work
Not necessarily. It often means we adjust the dose or choose a different option within the same class. We monitor response and side effects and change course if needed. cpicpgx.org

Do I need to repeat the test later
Usually no. Because your DNA does not change, the same report can inform future decisions. Bring a copy to new providers. M Health Fairview

Is this only for psychiatry
No. Many specialties use pharmacogenomics. The FDA maintains a table of medications with pharmacogenomic information in their labeling across multiple fields. U.S. Food and Drug Administration

How we use testing in our practice

In our Cookeville and Crossville offices we offer pharmacogenomic testing when it can add clarity or safety. We order it when results are likely to change the plan or reduce trial and error. We review the findings with you in plain language, note any specific dosing suggestions from respected guidelines, and decide next steps together. For many people the best choice is still a careful trial of medication without testing first, and that is perfectly reasonable. cpicpgx.org+1

The bottom line

Genetic testing for medications can make treatment more personal. It helps us choose a starting point with more confidence, avoid certain risks, and adjust more precisely. It does not replace your story, your goals, or ongoing follow up. If you want to talk about whether testing makes sense for you, schedule a visit. We are here to help you find a clear plan that fits your life.

Educational content only. This article is not a substitute for medical advice. Always talk with your clinician before making changes to medication.